Prevail Therapeutics Inc (PRVL) Stock Analyst Ratings
NASDAQ:PRVL - Nasdaq -
ChartMill assigns a Buy % Consensus number of 73% to PRVL. The Buy consensus is the weighted average rating of the current analysts ratings.
PRVL was analyzed by 9 analysts. The buy percentage consensus is at 73. So analysts seem to be have mildly positive about PRVL.
In the previous month the buy percentage consensus was at a similar level.
PRVL was analyzed by 9 analysts. More opinions would make the average more meaningful.